345891-28-3

Basic information

• Product Name: METHYL 5-BROMO-2-METHYLFURAN-3-CARBOXYLATE
• Synonyms: METHYL 5-BROMO-2-METHYLFURAN-3-CARBOXYLATE
• CAS NO: 345891-28-3
• Molecular Formula: C₇H₇BrO₃
• Molecular Weight: 219.03268
• Mol File: 345891-28-3.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: METHYL 5-BROMO-2-METHYLFURAN-3-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 5-BROMO-2-METHYLFURAN-3-CARBOXYLATE(345891-28-3)
• EPA Substance Registry System: METHYL 5-BROMO-2-METHYLFURAN-3-CARBOXYLATE(345891-28-3)

Safety Data

• Hazardous Substances Data: 345891-28-3(Hazardous Substances Data)

Upstream product

• 6141-58-8 methyl 2-methyl-3-furancarboxylate 

Downstream Products

• 934247-58-2 C₂₈H₂₅NO₇ 
• 934247-57-1 C₂₉H₂₇NO₇ 
• 1334598-56-9 C₁₄H₁₃NO₄ 
• 29113-73-3 methyl 2-methyl-5-phenylfuran-3-carboxylate 
• 1334598-39-8 C₁₅H₁₄O₄ 
• 108124-17-0 2-methyl-5-phenyl-furan-3-carboxylic acid 
• 1334598-63-8 C₁₄H₁₂O₄ 
• 1334598-62-7 C₁₄H₁₂O₄ 
• 1334599-03-9 C₂₀H₂₀N₂O₄S 
• 1334599-02-8 C₂₀H₂₀N₂O₃S 
• 1334599-01-7 C₁₉H₁₈N₂O₃S 
• 1334598-27-4 C₂₁H₂₁N₃O₃S 
• 1334598-25-2 C₁₉H₁₇N₃O₃S 
• 1334598-21-8 C₁₉H₁₈N₂O₄S₂ 

Relevant articles and documents

A furan [2, 3 - c] pyridine derivative and its preparation and use (by machine translation)

The invention relates to a furan [2, 3 - c] pyridine derivative and its preparation and use. The invention discloses a kind of potent prolyl hydroxylase inhibitor, the present invention relates to compounds of the formula I structure, and it also relates

Total synthesis of (+)-Z-deoxypukalide, a furanobutenolide-based cembranoid isolated from the pacific octocoral Leptogorgia spp.

A total synthesis of (+)-Z-deoxypukalide 3 using a combination of Stille and Nozaki-Hiyama-Kishi(NHK) coupling reactions as key steps, is described. During this study a new practical synthesis of the substituted butenolide intermediate 10, based on a comb

BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF

The bicyclo-substituted pyrazolon-azo derivatives of formula (I) or pharmaceutical acceptable salts, hydrates or solvates thereof, methods for their preparation, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor are disclosed. The definition of substituents in formula (I) are the same as defined in the description.